Key research themes
1. How is intracellular Ca2+ signaling machinery organized and regulated in Caco-2 cells during differentiation and what are the implications for cellular function?
This theme focuses on the molecular and functional remodeling of calcium (Ca 2+) signaling components—including Store-Operated Calcium Entry (SOCE), STIM/Orai/TRPC proteins, calcium oscillations, and associated channels—in Caco-2 cells as they differentiate. Understanding these mechanisms is vital because Ca 2+ signals tightly regulate key cellular processes such as proliferation, differentiation, barrier formation, and metabolism, which are especially relevant to the enterocyte-like phenotype of differentiated Caco-2 monolayers that serve as intestinal epithelial models.
2. What roles does ER-mitochondrial Ca2+ transfer and associated organellar cross-talk play in regulating cellular metabolism and fate in Caco-2 cells and related epithelial systems?
This theme explores the molecular mechanisms and physiological implications of Ca 2+ communication between the endoplasmic reticulum (ER) and mitochondria, focusing on the importance of mitochondria-associated ER membranes (MAMs) and Ca 2+ channels (e.g., IP3Rs, VDAC1, MCU) in shaping metabolic signaling, apoptosis, and cellular bioenergetics. These processes are key for Caco-2 cell function and differentiation given their dependence on regulated Ca 2+ signaling for maintaining homeostasis and responding to metabolic demands.
3. How does store-operated calcium entry (SOCE) through STIM and Orai proteins influence cancer stemness, chemoresistance, and cellular proliferation in Caco-2 cells and related carcinoma contexts?
This theme investigates the role of key SOCE components—STIM and Orai proteins—in regulating Ca 2+ influx critical for sustaining cancer stem cell (CSC) traits, promoting resistance to chemotherapy, and influencing tumor cell proliferation. Given that Caco-2 cells derive from colon carcinoma and exhibit differentiation-dependent changes in Ca 2+ signaling, deciphering SOCE’s contribution to these oncogenic features is essential to therapeutically targeting CRC and overcoming drug resistance.